Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

São Paulo City Will Require Proof of Vaccination to Enter Shops, Bars

08/23/2021 | 12:24pm EDT

By Luciana Magalhães and Jeffrey T. Lewis

SÃO PAULO--The biggest city in South America plans to require people to show proof they've received at least one shot of a vaccine against Covid-19 to enter bars, shops, restaurants, shopping centers, soccer matches and other commercial establishments and events, São Paulo's city hall said Monday.

The plan is for the program to start on Aug. 30, and establishments will be required to check their customers' vaccination status. Any that are caught ignoring the rule will be fined, São Paulo Mayor Ricardo Nunes said during a press conference. The size of the fine and some other details haven't been decided yet.

The city's approximately 12.3 million residents will be able to download an app that will generate a QR code containing the necessary information. People without a smartphone or who were vaccinated outside of the city will be able to show their vaccination cards as proof of their status.

The app will also be used to remind people who have only had one shot of a two-shot vaccine to get the second jab, and will contain some other medical information of the people who download it, according to São Paulo city hall. About 211,000 residents of the city have gotten their first shot but not the second, Mr. Nunes said.

São Paulo state is home to South America's biggest maker of vaccines, the Instituto Butantan, which has produced more than 75 million doses of the Coronavac vaccine, made under license from Chinese company Sinovac. Brazil has also approved the use of the AstraZeneca, Pfizer and Johnson & Johnson's vaccines.

The state's vaccination campaign has advanced rapidly in recent weeks, with 96.9% of the population over 18 receiving at least one shot as of Monday, and 32.9% having finished the vaccination process, according to the state government's website. São Paulo is Brazil's most populous state, with 46 million people.

About 75% of Brazil's adult population of about 160 million have already received at least one vaccine shot and Brazilian authorities hope to have vaccinated the country's whole adult population by the end of September.

São Paulo's neighboring municipality of Guarulhos, site of the region's international airport, said last week it will start requiring proof of vaccination to enter bars, shops, restaurants, schools and other establishments beginning on Sept. 1, according to local reports.

Write to Luciana Magalhães at luciana.magalhaes@wsj.com

(END) Dow Jones Newswires

08-23-21 1424ET

Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.74% 9007 Delayed Quote.22.09%
JOHNSON & JOHNSON 0.22% 164.08 Delayed Quote.4.26%
PFIZER, INC. -0.02% 43.15 Delayed Quote.17.25%
SINOVAC BIOTECH LTD. -0.31% 6.47 Delayed Quote.0.00%
All news about ASTRAZENECA PLC
02:58aVACCINATED BUT STUCK : Indians await WHO nod for homegrown shot to travel abroad
RE
10/25ASTRAZENECA : Daiichi Sankyo in Clinical Trial Collaboration to Evaluate Datopotamab Derux..
MT
10/25WALL STREET STOCK EXCHANGE : 84% of Q3 earnings reports exceed expectations
10/25ANALYST RECOMMENDATIONS : American Express, Beyond Meat, Microsoft, Oracle, Weibo...
10/25UNIVERSITY OF BIRMINGHAM : A third of leukaemia patients do not generate any antibody resp..
AQ
10/25ASTRAZENECA : Imfinzi plus chemotherapy significantly improved overall survival in 1st-lin..
AQ
10/25ASTRAZENECA : JP Morgan reiterates its Buy rating
MD
10/25ASTRAZENECA : Imfinzi plus chemotherapy significantly improved overall survival in 1st-lin..
PU
10/25ASTRAZENECA : S.Korea to donate 1 mln doses of AstraZeneca's vaccine to Iran -KDCA
RE
10/25Medivir Appoints Jens Lindberg as Chief Executive Officer
AQ
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 441 M - -
Net income 2021 4 862 M - -
Net Debt 2021 24 715 M - -
P/E ratio 2021 35,6x
Yield 2021 2,29%
Capitalization 191 B 191 B -
EV / Sales 2021 6,08x
EV / Sales 2022 4,92x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 123,07 $
Average target price 137,82 $
Spread / Average Target 12,0%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC22.09%190 828
JOHNSON & JOHNSON4.26%431 938
ROCHE HOLDING AG15.61%338 364
NOVO NORDISK A/S59.69%243 351
PFIZER, INC.17.25%241 929
ELI LILLY AND COMPANY45.14%222 158